These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
200 related items for PubMed ID: 6734702
1. Comparative pharmacokinetic analysis of a novel sustained-release dosage form of theophylline in humans. Raz I, Bialer M, Salame K, Bar-On H. Eur J Clin Pharmacol; 1984; 26(3):401-3. PubMed ID: 6734702 [Abstract] [Full Text] [Related]
2. Effect of sustained-release on the pharmacokinetics of theophylline in healthy subjects. Bialer M, Salame K, Raz I. Int J Clin Pharmacol Ther Toxicol; 1985 Dec; 23(12):662-7. PubMed ID: 4093206 [Abstract] [Full Text] [Related]
3. Effect of food on bioavailability and pharmacokinetics of theophylline following administration of two sustained release dosage forms: Part I. Ohmori N, Inotsume N, Matsukura M, Higashi A, Iwaoku R, Tobino Y, Nakano M, Matsuda I. Int J Clin Pharmacol Ther Toxicol; 1986 Mar; 24(3):148-52. PubMed ID: 3699941 [Abstract] [Full Text] [Related]
4. Absorption of sustained-release theophylline tablets. Fagerström PO, Heintz L. Int J Clin Pharmacol Ther Toxicol; 1983 Jul; 21(7):359-62. PubMed ID: 6885207 [Abstract] [Full Text] [Related]
5. Absorption of theophylline from conventional and sustained-release tablets. Fagerström PO, Mellstrand T, Svedmyr N. Int J Clin Pharmacol Ther Toxicol; 1981 Mar; 19(3):131-8. PubMed ID: 7228455 [Abstract] [Full Text] [Related]
9. Comparison of aminophylline and theophylline sustained-release formulations by their bioavailability and steady-state serum levels. Steinijans VW, Zech K, Fischer R. Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):624-30. PubMed ID: 6668100 [Abstract] [Full Text] [Related]
10. Absorption of theophylline from enteric coated and sustained release formulations in fasted and non-fasted subjects. Osman MA, Patel RB, Irwin DS, Welling PG. Biopharm Drug Dispos; 1983 Dec; 4(1):63-72. PubMed ID: 6839003 [Abstract] [Full Text] [Related]
11. Study of bioavailability and pharmacokinetics of theophylline following administration of two sustained release dosage forms as assessed by salivary data: Part II. Ohmori N, Inotsume N, Matsukura M, Higashi A, Iwaoku R, Tobino Y, Nakano M, Matsuda I. Int J Clin Pharmacol Ther Toxicol; 1986 Apr; 24(4):196-201. PubMed ID: 3710632 [Abstract] [Full Text] [Related]
12. Absorption of theophylline from conventional and sustained-release tablets. Mellstrand T, Svedmyr N, Fagerström PO. Eur J Respir Dis Suppl; 1980 Apr; 109():54-60. PubMed ID: 6934088 [Abstract] [Full Text] [Related]
13. Absorption properties of two theophylline sustained-release products in smokers. Miller R, Rheeders M. S Afr Med J; 1984 Jun 30; 65(26):1045-8. PubMed ID: 6740419 [Abstract] [Full Text] [Related]
17. Performance of a modified starch hydrophilic matrix for the sustained release of theophylline in healthy volunteers. Vandenbossche GM, Lefebvre RA, De Wilde GA, Remon JP. J Pharm Sci; 1992 Mar 30; 81(3):245-8. PubMed ID: 1640362 [Abstract] [Full Text] [Related]
18. Theophylline absorption from sustained-release products: comparative steady-state bioavailability of once-daily Theo-Dur, Theo-24, and Uniphyl. Hurwitz A, Karim A, Burns TS. J Clin Pharmacol; 1987 Nov 30; 27(11):855-61. PubMed ID: 3429692 [Abstract] [Full Text] [Related]
19. The rise and fall of serum theophylline concentration: a comparison of sustained-release formulations in volunteers with rapid theophylline clearance. Mucklow JC, Kuhn S. Br J Clin Pharmacol; 1985 Dec 30; 20(6):589-96. PubMed ID: 4091990 [Abstract] [Full Text] [Related]
20. Absorption of theophylline from a sustained-release theophylline tablet formulation, Theo-Dur. Takagi K, Hasegawa T, Ogura Y, Yamaki K, Suzuki R, Satake T, Imaeda N, Mizukami Y. Int J Clin Pharmacol Ther Toxicol; 1987 Oct 30; 25(10):530-5. PubMed ID: 3429057 [Abstract] [Full Text] [Related] Page: [Next] [New Search]